115 filings
8-K
XCUR
Exicure Inc
16 May 24
Exicure, Inc. Reports Third Quarter 2023 Financial Results
4:50pm
8-K
XCUR
Exicure Inc
22 Apr 24
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
4:20pm
8-K
XCUR
Exicure Inc
5 Feb 24
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
4:16pm
8-K
XCUR
Exicure Inc
16 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
XCUR
Exicure Inc
1 Dec 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
8-K
leei9bkn
28 Nov 23
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
4:19pm
8-K
lkquviisr7 dluj1zjmh
6 Oct 23
Other Events
5:03pm
8-K
uhg 3cptr1kzvpo9
27 Sep 23
Departure of Directors or Certain Officers
5:25pm
8-K
5tmh49l5pth rtxkwx
13 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
fxdnm1fo i8m6vx
23 Aug 23
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
9:29am
8-K
tr4yzq6hfmpv45h1fbm
11 Aug 23
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:18pm
8-K
zr8nbt li418af
9 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:24pm
8-K
9prjhfiy68gnv6322n0g
4 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:23pm
8-K
i90w3iv7hf8hr48
14 Jul 23
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
nh2wvwv
14 Jun 23
Departure of Directors or Certain Officers
4:46pm
8-K
5rbdku9 4v0ymeykb0
6 Jun 23
Changes in Registrant's Certifying Accountant
4:34pm
8-K
ax2xwif5bb995o0dvn
1 Jun 23
Departure of Directors or Certain Officers
5:21pm
8-K
g91pred 4gg4on25h0
26 May 23
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
4:22pm
8-K
hhpy67rwapav
19 May 23
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
4:24pm
8-K
gtxo0b4edq0 tdqx
18 May 23
Entry into a Material Definitive Agreement
4:39pm